MKI67 and gastrointestinal stromal tumor: In a clinicopathological and IHC study of GIST, it was discovered that the higher the expression level of Ki-67, the poorer the long-term prognosis of the patient and the reliability of Ki-67 for prognosis evaluation was better than other protein markers, especially in the high-risk group patients (23).